Cerebral platelet thromboembolism and thromboxane synthetase inhibition

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Platelet aggregating sodium arachidonate was slowly infused into the internal carotid artery (1 mg, 100 µl, 1µl/s) of nitrous oxide anesthetized rats. The electroencephalographic activity recorded by a Cerebral Function Monitor from the injected hemisphere was reduced within minutes. The so matose nsory evoked responses to contralateral electrical stimulation of the whisker area were eliminated on the same side in most cases when measured five and fifteen minutes after the infusion. The brain was frozen in situ with liquid nitrogen after fifteen minutes. Regional tissue analysis showed ipsilateral derangement of the cerebral energy state and increased lactate levels. Pretreatment with the platelet antlaggregating thromboxane synthetase inhibitor OKY-1581 (Sodium-3-4-(3-pyridylmethyl)phenyl-2-methyI-acry-late), 30 mg/kg i.v., fifteen minutes before the sodium arachidonate infusion prevented cerebral energy failure and elimination of the sensory evoked responses. © 1985 American Heart Association, Inc.

Cite

CITATION STYLE

APA

Fredriksson, K., Rosén, I., Johansson, B. B., & Wieloch, T. (1985). Cerebral platelet thromboembolism and thromboxane synthetase inhibition. Stroke, 16(5), 800–805. https://doi.org/10.1161/01.STR.16.5.800

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free